Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 

     




Investor Research for Marijuana Stocks

Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

 

Interview with Timothy Taggart, CEO of American Growth Fund Series Two (AMREX), currently the only Cannabis Mutual Fund in the US

Marijuana News

#Cannabis Stock News: OWC (OTC: $OWCP) Pharmaceutical Research to Present at Lyons Capital’s Wall Street Conference
PETACH TIKVA, Israel - February 17, 2017 (Investorideas.com Newswire) OWC Pharmaceutical Research Corp. (OTC: OWCP), ("OWC" or the "Company"), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced that it will be presenting at the Wall Street Conference.

#Cannabis Stock News: CTT Pharmaceutical Holdings (OTCQB: $CTTH) and CanniMed Therapeutics Inc. (TSX: $CMED) Complete Exclusive Canadian Licensing Agreement for #Cannabis Orally Dissolvable Thin Film (ODF) Wafer
SASKATOON, Saskatchewan and STONEY CREEK, Ontario - February 17, 2017 (Investorideas.com Newswire) Today, CanniMed Therapeutics Inc. (TSX: CMED) and CTT Pharmaceutical Holdings Inc. (OTCQB:CTTH) have entered into a definitive contractual relationship for the licensing of CTT's Orally Dissolvable Thin Film (ODF) Wafer technology.

#Cannabis Stock News: CannaRoyalty (CSE: $CRZ) (CSE:CRZ.CN) Completes 20% Acquisition of Anandia Labs, a Leader in Cannabis Testing, Extraction and Genetics
OTTAWA, ONTARIO - February 17, 2017 (Investorideas.com Newswire) CannaRoyalty Corp. (CSE:CRZ)(CSE:CRZ.CN) ("CannaRoyalty" or the "Company") is pleased to announce the closing of its previously announced acquisition of a 20% equity stake in Anandia Laboratories Inc. ("Anandia Labs"), a cutting-edge cannabis biotechnology company, in exchange for aggregate consideration of C$4,042,439.09.

Petrone Worldwide, Inc. (OTCQB: $PFWI) is Finalizing Plans to Enter the Multi-Billion Dollar Cannabis Market
WESTON, FL - February 17, 2017 (Investorideas.com Newswire) Petrone Worldwide, Inc. (OTCQB: PFWI), a leader in the hospitality industry with global operations capabilities, announces today that the Company is in the process of entering the cannabis market in the very near future.

#Cannabis Stock News: Cannabix Technologies (CSE:BLO) (CSE:BLO.CN) Provides Update on Marijuana Breathalyzer Development
VANCOUVER, BRITISH COLUMBIA - February 16, 2017 (Investorideas.com Newswire) Cannabix Technologies Inc. (CSE:BLO)(CSE:BLO.CN)(OTC PINK:BLOZF) (the "Company or Cannabix") developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to provide a development update on its FAIMS Beta 2.0 (field asymmetric waveform ion mobility spectrometry) based marijuana breathalyzer for the detection of ∆9-tetrahydrocannabinol ("THC") in human breath.

#Cannabis Stock News: UPDATE: Tetra Bio-Pharma (CSE:TBP) (CSE:TBP.CN) (OTC PINK:GRPOF) Reports Approval by Health Canada of its Phase I Trial of PPP001 (dried Cannabis)
OTTAWA, ONTARIO - February 16, 2017 (Investorideas.com Newswire) PhytoPain Pharma Inc. (PPP), a subsidiary of Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE:TBP)(CSE:TBP.CN)(OTC PINK:GRPOF), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain is pleased to announce that the Therapeutic Products Directorate (TPD) of Health Canada has approved its Phase I clinical study of smoked cannabis.

What's Driving the global legal marijuana market?
February 16, 2017 (Investorideas.com Newswire) Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks, releases its 5th excerpt of its cannabis /hemp stock directory for investors following the sector and provides commentary from Technavio on four key drivers for the industry.

#Cannabis Stock News: Amfil Technologies Inc. (OTC: $AMFE) Expands on its GROzone Product Line Which Is Designed to Eliminate Pesticide Use in the Medical Marijuana Industry
TORONTO, ON - February 16, 2017 (Investorideas.com Newswire) Amfil Technologies Inc. (OTC PINK: AMFE) is pleased to give an overview of its GROzone product line and where it stands today.

#Cannabis Stock News: Vinergy Resources (CSE: $VIN) (OTCQB: $VNNYF) /MJ BioPharma Appoint John Simon to Scientific Advisory Board
VANCOUVER, BRITISH COLUMBIA - February 16, 2017 (Investorideas.com Newswire) Vinergy Resources Ltd. ("Vinergy" or the "Company") (CSE:VIN)(OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ BioPharma (announced December 14, 2016) is pleased to announce that, as a part of the Company's strategy to develop a lab for research and development products that test and identify specific cannabinoid isolates for targeted therapeutic purposes, it has appointed John Simon to the Company's Scientific Advisory Board (SAB).

#Viridian Cannabis Deal Tracker for Week Ended 2/10/2017
February 14, 2017 (Investorideas.com Newswire) Viridian Capital Advisors, LLC reports on its weekly Viridian CANNABIS DEAL TRACKER for the week ending February 10, 2017.

Subscribe to Marijuana News RSS

Submit Articles   Search More Articles

Cannabis Law News | Cannabis Law Report

Stock Quotes

Marijuana / Hemp Stock Directory Preview

22nd Century Group Inc. (NYSE MKT:XXII) is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants through genetic engineering and plant breeding. The Company's primary mission is to reduce the harm caused by smoking. 22nd Century currently owns or exclusively controls more than 200 issued patents and more than 50 pending patent applications around the world. The Company's strong IP position led to a licensing agreement with British American Tobacco ("BAT"), the world's second largest tobacco company.

ABATTIS BIOCEUTICALS (OTC:ATTBF) is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The Company is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions, by supplying and partnering with companies to employ its mass cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. The Company also has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions.

Acology Inc (OTC:ACOL) markets and sells the TSOS Container™ (The Science of Storage).This container is the first-ever FDA approved polypropylene air-tight, water-tight, smell-proof delivery and storage container with a built-in grinder. It is manufactured from medical-grade No. 5 polypropylene resin, which is non-porous and non-leaching. These containers are portable and affordable. he Medtainer™ allows patients to store, grind and pour a variety of medications, including pills and all sizes and solidity, herbal medications and teas and even coffee and spices! The Medtainer™ can be ordered in with a certified child-resistant cap. Each Medtainer™ is water-proof and smell proof. Caregivers who are responsible for ensuring their patients medication regimens are universally pleased with the how easy and effective the Medtainer™ grind medications. It is an excellent solution for patients with dysphasia due to cognitive disorders or brain injuries, are in hospice or palliative situations and for anyone who would rather not swallow whole pills. The MedTainer™ was originally developed for geriatric and pediatric patients who had difficulty swallowing pills or needed an effective alternative to costly name-brand medications. The MedTainer™ has been sold and is being successfully used throughout the United States, Canada, Mexico and South America and Europe. Our association with the Medical Marijuana community was an unexpected windfall that has given Acology, Inc. the necessary funding to expand into the growing hospice and palliative care markets, and to help countless patients who are living at home or in small home-like settings and need help swallowing pills.

Advantis Corp (OTC:ADVT) develops products and works with developing companies to provide innovative healthcare products, holistic pain management solutions, and enhance the footprint in the evolving legal cannabis business. Advantis acquires ownership in developing companies that work within the nutraceutical and the alternative health care industries; consulting with these organizations to improve their product lines, expand their distribution channels through internal partnership agreements, and heighten brand value.

AeroGrow International, Inc. (OTC:AERO) Headquartered in Boulder, Colorado, AeroGrow International, Inc. is the leader in the rapidly growing indoor gardening category. AeroGardens allow anyone to grow farmer's market fresh herbs, salad greens, tomatoes, chili peppers, flowers and more, indoors, year-round, so simply and easily that no green thumb is required. With an AeroGarden... you can grow anything! In April 2013, AeroGrow entered into a strategic partnership with Scotts Miracle-Gro to continue to expand the indoor gardening market.

AFFINOR GROWERS (CSE:AFI; OTC:RSSFF) is focused on growing high quality crops such as romaine lettuce, spinach, strawberries and high quality medical Marijuana. Affinor is committed to becoming a pre-eminent grower, using exclusive vertical farming techniques.

Agritek Holdings Inc (OTC:AGTK) a fully reporting Company and pioneer within the medicinal marijuana space provides innovative patient and agricultural solutions seeks to be the leader in Compassionate Care Technology for the medicinal marijuana industry. Agritek Holdings provides real estate management and health and wellness product lines through its wholly-owned subsidiary, Agritek Holdings Inc.  Agritek Holdings Inc. does not directly grow, harvest, or distribute or sell cannabis or any substances that violate United States law or the Controlled Substances Act, nor does it intend to do so in the future.

Alliance Growers Corp. (CSE:ACG) is a cannabis company dedicated to building shareholder value through its 4 Pillars business strategy. The company was incorporated in 2014 and is publicly traded on the CSE under the symbol ACG. The company's head office is in Vancouver, BC and its interest in a marijuana production facility in Kelowna, BC.

Alternative Energy Partners, Inc. (OTC:AEGY) a development stage company, is engaged in providing support services for medical marijuana collectives based in California. It focuses on developing PharmaJanes, a multi-tiered application that allows individuals to place orders for medical marijuana through a Website and smart phone application. The company was founded in 2008 and is based in Boca Raton, Florida.

American Cannabis Company, Inc. (OTC:AMMJ) offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. Through our two vertically integrated businesses, American Cannabis Consulting and American Cultivator Company, a group purchasing organization, we support our clients from concept to creation to commercialization to on-going operations.

See the full stock directory here

 

Investor Resources

Expert Corner Michael J. Swartz, Analyst Viridian Capital & Research, LLC

Michael Swartz

Mr. Swartz serves as Senior Analyst at Viridian Capital & Research, where he leads all modeling and valuation work for the firm’s M&A and fund raising assignments. He served as co-portfolio manager for the Osprey Financial Group, where he analyzed publicly traded companies with market capitalizations from $50 million to $1 billion and prepared buy-side equity reports containing buy-recommendations and original valuations derived from fundamental & technical analysis. In addition, Mr. Swartz served as the fund’s Asian Economist, analyzing economic and geopolitical factors and assessing the Asia-Pacific region for attractive investment opportunities. Previously, Mr. Swartz worked as an Analyst at TBG Holdings, assisting clients with researching strategic options as it relates to market opportunities, competitive positioning, and allocation of resources. Mr. Swartz holds a B.B.A. in Finance and minor in Criminal Justice from the University of North Florida.

CANNABIS STOCKS: 2014 REVIEW AND 2015 OUTLOOK

Viridian Cannabis Index Gains 38.4% for 2014
Cannabis Stocks Will Attract More Institutional Funding in ’15 and M&A Activity Will Rise
More Companies Will Fail as Shake Out Continues

More institutional capital will flow into public cannabis companies in 2015, reflecting the sector’s growth prospects, but some individual companies will falter as investors and regulators demand performance. The backdrop and general momentum of the cannabis sector is positive as the reality of its national growth potential becomes more and more apparent, but the shake out of individual players that began last year will continue in 2015, as hype will not be enough to sustain companies in the eyes of investors, and may contribute to action by regulators. We will likely see a number of public cannabis companies fail this year. With increasing flows of ‘smart money’ will come increasing demand for companies to demonstrate top-tier management and sustainable business models.

Report in pdf